Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Next Deadline
161 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
January 09, 2026
Extension Available
Until July 09, 2025
Application History
23 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 8, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 7, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 7, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jul 7, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jan 7, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jan 7, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Jan 7, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 7, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 9, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
May 14, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 14, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 24, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 8, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 1, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Apr 1, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 1, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 27, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 27, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Mar 27, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 20, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Mar 20, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 20, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Feb 26, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Additional Information
Design Mark
The mark consists of thick outlines of two back-to-back ovals with the outside facing sides indented, all in the colors light blue and dark blue. The color white represents transparent areas and is not part of the mark.
Color Claim
The color(s) light blue and dark blue is/are claimed as a feature of the mark.
Classification
International Classes
005